ArticleBritish journal of cancer2024

TRIM21/USP15 balances ACSL4 stability and the imatinib resistance of gastrointestinal stromal tumors.

Zhiwei Cui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.